Briganix (Brigatinib) 180 MG – 30 Tablets

$660.00

Brigatinib 180 mg (Briganix) is a medication used to treat a specific type of advanced lung cancer called non-small cell lung cancer (NSCLC) when it’s positive for a genetic mutation called anaplastic lymphoma kinase (ALK). It’s for patients whose cancer has spread and who have either not responded well to, or can’t tolerate, another medication called crizotinib.